pneumococcal conjugate CRM vaccine / Panacea Biotec - LARVOL DELTA

Human health implications of emerging diseases and the current situation in India's vaccine industry. (PubMed, Sci One Health) - "With heavy privatesector investments, Indian pharmacology now provides core Expanded Programme on Immunization vaccines to United Nations International Children's Emergency Fund, producing previously unattainable vaccines for diseases like meningitis, hepatitis B, pneumococcal conjugate, rotavirus, influenza A (H1N1), and COVID-19...The Serum Institute has developed several vaccines, including Nasovac, MenAfriVac, Pentavac, and an inactivated polio vaccine...Despite its booming economy and technical advances, India's disproportionate share of the world's child mortality rate remains unchanged. However, the growing production and distribution of vaccinations in developing nations has initiated a new era, leading to a worldwide decline in childhood death and disease."

Journal • Review • CNS Disorders • Hepatitis B • Hepatology • Infectious Disease • Inflammation • Influenza • Measles • Novel Coronavirus Disease • Pertussis • Pneumococcal Infections • Respiratory Diseases • Rotavirus Infections • Tetanus